2020
2019
2018
2017
  • Teixeira FR, Manfiolli AO, Vieira NA, Medeiros AC, Coelho PO, Santiago Guimarães D, Schechtman D, Gomes MD. FBXO25 regulates MAPK signaling pathway through inhibition of ERK1/2 phosphorylation. Arch Biochem Biophys. 2017 May 1;621:38-45.

  • Valenzuela-Oses JK, García MC, Feitosa VA, Pachioni-Vasconcelos JA, Gomes-Filho SM, Lourenço FR, Cerize NNP, Bassères DS, Rangel-Yagui CO. Development and characterization of miltefosine-loaded polymeric micelles for cancer treatment. Mater Sci Eng C Mater Biol Appl. 2017 Dec 1;81:327-333.

  • Pellegrina, D. V. S., Severino, P., Barbeiro, H. V., de Souza, H. P., Machado M. C.C, da Silva F.P., Reis E. M. (2017) Insights into the Function of Long Noncoding RNAs in Sepsis Revealed by Gene Co-Expression Network Analysis. Non-Coding RNA 3:1-5

  • Chevalier MT, García MC, Gonzalez D, Gomes-Filho SM, Bassères DS, Farina H, Alvarez VA. Preparation, characterization and in vitro evaluation of ε-polylysine-loaded polymer blend microparticles for potential pancreatic cancer therapy. J Microencapsul. 2017 Sep 3:1-10.

  • Yong KJ, Bassères DS, Welner RS, Zhang WC, Yang H, Yan B, Alberich-Jorda M, Zhang J, de Figueiredo-Pontes LL, Battelli C, Hetherington CJ, Ye M, Zhang H, Maroni G, O'Brien K, Magli MC, Borczuk AC, Varticovski L, Kocher O, Zhang P, Moon YC, Sydorenko N, Cao L, Davis TW, Thakkar BM, Soo RA, Iwama A, Lim B, Halmos B, Neuberg D, Tenen DG, Levantini E.  Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression. Sci Transl Med. 2016 Aug 3;8(350):350ra104.

2016
  • dos Santos EO, Carneiro-Lobo TC, Aoki MN, Levantini E, Bassères DS. Aurora kinase targeting in lung cancer reduces KRAS-induced transformation. Mol Cancer, 15:12, 2016.

  • Oliveira PS, Ferraz FAN, Pena DA, Pramio DT, Morais FA & Schechtman D. Revisiting protein kinase–substrate interactions: Toward therapeutic development. Sci, Signal. 22 Mar, 2016 Re3

  • Pena DA, Andrade VP, Silva GÁ, Neves JI, Oliveira PS, Alves MJ, Devi LA & Schechtman D. Rational design and validation of an anti-protein kinase C active-state specific antibody based on conformational changes. Sci Rep. 2016 Feb 25;6:22114.

  • Canevari R.A., Marchi F.A., Domingues M.A.C., Andrade V.P., Caldeira J.R.F., Verjovski-Almeida S., Rogatto S.R., Reis E.M. (2016) Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma. Tumor Biology,: p. 1-16.

  • Qvit N, Schechtman D, Pena DA, Berti DA, Soares CO, Miao Q, Liang LA, Baron LA, Teh-Poot C, Martínez-Vega P, Ramirez-Sierra MJ, Churchill E, Cunningham AD, Malkovskiy AV, Federspiel NA, Gozzo FC, Torrecilhas AC, Manso Alves MJ, Jardim A, Momar N, Dumonteil E, Mochly-Rosen D. Scaffold proteins LACK and TRACK as potential drug targets in kinetoplastid parasites: Development of inhibitors. Int J Parasitol Drugs Drug Resist. 2016 Feb 12;6(1):74-84.

2015
2014
  • Bassères DS, Ebbs A, Cogswell PC, Baldwin AS. IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity. Genes Cancer 5(1-2):41-55, 2014.

  • Dan HC, Ebbs A, Pasparakis M, Van Dyke T, Bassères DS, Baldwin AS. Akt-Dependent Activation of mTORC1 Involves Phosphorylation of mTOR by IKKalpha. J Biol Chem, 289(36):25227-40, 2014.

  • Duarte ML, Pena DA, Nunes Ferraz FA, Berti DA, Paschoal Sobreira TJ, Costa-Junior HM, Abdel Baqui MM, Disatnik MH, Xavier-Neto J, Lopes de Oliveira OS & Schechtman D. Protein folding creates structure-based, noncontiguous consensus phosphorylation motifs recognized by kinases. Sci Signal. 2014 Nov 4;7(350):ra105.

2013
2012
  • Bassères DS, D’Alò F, Yeap BY, Lowenberg EC, Gonzalez DA, Yasuda H, Dayaram D, Kocher ON, Godleski JJ, Richards WG, Meyerson M, Kobayashi S, Tenen DG, Halmos B, Costa DB. Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing. Lung Cancer, 77: 31-37, 2012.
2011
  • Tahira A.C., Kubrusly M.S., Faria M.F., Dazzani B., Fonseca R.S., Maracaja-Coutinho V., Verjovski-Almeida S., Machado M.C., Reis E.M. (2011). Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer. Molecular Cancer,10:141.

  • Levantini E, Lee S, Radomska HS, Hetherington CJ, Alberich-Jorda M, Amabile G, Zhang P, Gonzalez D, Zhang J, Bassères DS, Wilson NK, Koschmieder S, Huang G, Zhang D, Ebralidze AK, Bonifer C, Okuno Y, Gottgens B, Tenen DG. RUNX proteins regulate gene expression in long-term hematopoietic stem cells by mediating interaction of distal and proximal regulatory elements. EMBO J, 30: 4059-4070, 2011.

2010
2009
2008
2007
2006

Departamento de Bioquímica
Instituto de Química
Universidade de São Paulo - USP

Av. Prof. Lineu Prestes, 748 sala 1208
Cidade Universitária
CEP 05508-000 - São Paulo - SP

Fone: +55-11-3091-2173
topo